Patents by Inventor Samina Khan

Samina Khan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140121164
    Abstract: The present invention relates to a dosage regime of a peptide analogues of [alpha]-melanocyte-stimulating hormone ([alpha]-MSH), which possesses an increased efficacy compared to the native [alpha]-MSH peptide in the treatment or prevention of kidney injury or disease.
    Type: Application
    Filed: October 31, 2013
    Publication date: May 1, 2014
    Inventors: SOREN NIELSEN, THOMAS ENGELBRECHT NORDKILD JONASSEN, SAMINA KHAN, MARK T. HOUSER, IB BO LUMHOLTZ, MICHAEL BECKERT, THOMAS BEAVER
  • Publication number: 20140100165
    Abstract: The present invention relates to a dosage regime of a peptide analogues of [alpha]-melanocyte-stimulating hormone ([alpha]-MSH), which possesses an increased efficacy compared to the native [alpha]-MSH peptide in the treatment or prevention of kidney injury or disease.
    Type: Application
    Filed: March 15, 2013
    Publication date: April 10, 2014
    Inventors: Soren Nielsen, Thomas Engelbrecht Nordkilk Jonassen, Samina Khan, Mark T. Houser, Ib Bo Lumholtz, Michael Beckert, Thomas Beaver
  • Publication number: 20140100162
    Abstract: The present invention relates to a dosage regime of a peptide analogues of [alpha]-melanocyte-stimulating hormone ([alpha]-MSH), which possesses an increased efficacy compared to the native [alpha]-MSH peptide in the treatment or prevention of kidney injury or disease.
    Type: Application
    Filed: June 20, 2013
    Publication date: April 10, 2014
    Applicant: AbbVie, Inc.
    Inventors: Soren Nielsen, Thomas Engelbrecht Nordkild Jonassen, Samina Khan, Mark T. Houser, Ib Bo Lumholtz, Michael Beckert, Thomas Beaver